MacroGenics
MGNX
127 hedge funds and large institutions have $270M invested in MacroGenics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 17 closing their positions.
59% more call options, than puts
Call options by funds: $78K | Put options by funds: $49K
2% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 46
3% less funds holding
Funds holding: 131 → 127 (-4)
3.37% less ownership
Funds ownership: 97.05% → 93.68% (-3.4%)
16% less capital invested
Capital invested by funds: $321M → $270M (-$50.6M)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.7M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.29M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$963K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$693K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$4.78M |
| 2 |
AC
Armistice Capital
New York
|
-$4.42M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.01M |
| 4 |
Two Sigma Advisers
New York
|
-$2.37M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.18M |
MGNX Hedge Fund Activity: Q3 2023 in Review
127 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2023, worth a combined $270M — down 16% from $321M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of MGNX and 13 opened new positions — a net loss of 4 holders — while 46 trimmed existing stakes and 45 added.
The largest buyer was Millennium Management, adding an estimated $5.1M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $4.78M sold.
- 127 institutional investors held MacroGenics (MGNX) as of Q3 2023, down from 131 in Q2 2023.
- Funds reported $270M of MacroGenics stock for Q3 2023, down 16% quarter-over-quarter.
- 13 funds opened new MacroGenics positions in Q3 2023 and 17 closed out, a net change of -4 holders.
- The largest MacroGenics buyer in Q3 2023 was Millennium Management, an estimated $5.1M added.
- The largest MacroGenics seller in Q3 2023 was Baker Bros. Advisors, an estimated $4.78M sold.
Based on aggregated 13F filings for Q3 2023.